Atlas Trials

Observational Prospective Study on Chemoembolization With Doxorubicin for Unresectable Hepatocellular Carcinoma

Clinical trial NCT01891539 · UNKNOWN

Trial details

NCT number
NCT01891539
Sponsor
International Group of Endovascular Oncology
Status
UNKNOWN
Study type
OBSERVATIONAL
Liver Cell Carcinoma Non-resectable
Start date
2013-05-01
Primary completion
2021-09-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.